These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35154090)

  • 21. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
    Galassi G; Marchioni A
    Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).
    Neubauer A; Johow J; Mack E; Burchert A; Meyn D; Kadlubiec A; Torje I; Wulf H; Vogelmeier CF; Hoyer J; Skevaki C; Muellenbach RM; Keller C; Schade-Brittinger C; Rolfes C; Wiesmann T
    Leukemia; 2021 Oct; 35(10):2917-2923. PubMed ID: 34385593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies.
    Ding Z; Wei X; Pan H; Shi H; Shi Y
    Scand J Immunol; 2024 Feb; 99(2):e13344. PubMed ID: 39007954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
    Mohkhedkar M; Venigalla SSK; Janakiraman V
    Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.
    Ravichandran S; Tang J; Grubbs G; Lee Y; Pourhashemi S; Hussaini L; Lapp SA; Jerris RC; Singh V; Chahroudi A; Anderson EJ; Rostad CA; Khurana S
    Nat Immunol; 2021 Nov; 22(11):1452-1464. PubMed ID: 34611361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.
    Kosyreva A; Dzhalilova D; Lokhonina A; Vishnyakova P; Fatkhudinov T
    Front Immunol; 2021; 12():682871. PubMed ID: 34040616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocytes and macrophages in COVID-19: Friends and foes.
    Meidaninikjeh S; Sabouni N; Marzouni HZ; Bengar S; Khalili A; Jafari R
    Life Sci; 2021 Mar; 269():119010. PubMed ID: 33454368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies.
    Ahmed SH; AlMoslemany MA; Witwer KW; Tehamy AG; El-Badri N
    Stem Cell Rev Rep; 2024 May; 20(4):900-930. PubMed ID: 38393666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat shock protein 27 in the pathogenesis of COVID-19 and non-COVID acute respiratory distress syndrome.
    Chiu MH; Gershkovich B; Yu IL; O'Brien ER; Deng J; McDonald B
    Cell Stress Chaperones; 2023 Nov; 28(6):877-887. PubMed ID: 37966617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection.
    Chen C; Amelia A; Ashdown GW; Mueller I; Coussens AK; Eriksson EM
    Mol Med; 2021 Dec; 27(1):160. PubMed ID: 34930107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Road Less Traveled: SARS-CoV-2 and Cell-Mediated Immunity.
    Morris KV
    Mol Ther; 2020 Dec; 28(12):2521-2522. PubMed ID: 33053318
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2.
    Zheng J; Miao J; Guo R; Guo J; Fan Z; Kong X; Gao R; Yang L
    Front Cell Infect Microbiol; 2022; 12():931061. PubMed ID: 35774402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
    Jouan Y; Guillon A; Gonzalez L; Perez Y; Boisseau C; Ehrmann S; Ferreira M; Daix T; Jeannet R; François B; Dequin PF; Si-Tahar M; Baranek T; Paget C
    J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32886755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.
    Nossent EJ; Schuurman AR; Reijnders TDY; Saris A; Jongerius I; Blok SG; de Vries H; Duitman J; Vonk Noordegraaf A; Meijboom LJ; Lutter R; Heunks L; Bogaard HJ; van der Poll T
    Front Immunol; 2021; 12():664209. PubMed ID: 34054832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
    Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E
    Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
    Harrell CR; Jovicic BP; Djonov V; Volarevic V
    Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
    Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
    Front Immunol; 2021; 12():691879. PubMed ID: 34163488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.